Ariel 4 (CANC 5651)

Trial description
A Phase 3 Multicenter, Open-label, Randomized Study of Rucaparib versus Chemotherapy in Patients with Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Contact name
Dr James Brenton
Trial start date
Tuesday, April 11, 2017
Trial end date
Wednesday, December 30, 2020
Trial tumour type
Show on Radiotherapy